Sergey Kantserov, MSc is an Investor Relations professional with particular experience in regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy and biopharmaceutics. Sergey has 3+ years experience in Russia (HSCI; Moscow Exchange: ISKJ)
We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.